Xenobots: The Future of Programmable Biological Machines

Picture of Patrick Wang

Patrick Wang

Expert of Peptides | Ask me anything about Peptides | Sales Manager at AHB Lab
xenobots

Table of Contents

The Emergence of Xenobots: A New Era in Science

In a groundbreaking scientific endeavor that blurs the line between life and machine, a team of researchers from the University of Vermont and Tufts University have created a new class of life forms known as “xenobots”. These living machines, constructed from the cells of frog embryos, are capable of moving, carrying payloads, and self-repairing after damage. This remarkable achievement represents a significant leap forward in both biological and computational science, opening up a world of possibilities for the future.

Figure Source: “A scalable pipeline for designing reconfigurable organisms”, published in Proceedings of the National Academy of Sciences (PNAS). Copyright © [2020], PNAS. Used under noncommercial and educational use policy.

 

Understanding Xenobots: A New Category of Life

The term “xenobots” comes from the African frog species Xenopus laevis, from which the cells used to create these organisms are derived. However, these entities are neither traditional robots nor known species of animals. Instead, they represent a new category of artifact: a living, programmable organism. This marks the first instance of designing completely biological machines from scratch, a feat that has never been accomplished before.

The design of the xenobots.
Image credits Sam Kriegman, Douglas Blackiston, Michael Levin, Josh Bongard, (2020), PNAS.

 

The Design Process: Creating Life from Scratch

The design process of these xenobots was a complex and intricate task. It involved the use of the Deep Green supercomputer cluster at the University of Vermont. An evolutionary algorithm was employed to generate thousands of potential body forms. Each design was a unique combination of a few hundred simulated cells, assembled in a way that would allow the xenobot to perform a specific task, such as moving in a particular direction.

 

From Design to Reality: The Birth of Xenobots

The most promising designs were then selected and brought to life by a team at Tufts University. The cells were assembled under a microscope to closely match the computer-generated designs. This process required a high degree of precision and skill, as the cells had to be cut and joined together in a way that would allow them to function as a coherent organism.

 

The Functionality of Xenobots: A Testament to Biological Systems

Once assembled, the cells began to work together in a way that was truly remarkable. They formed a passive skin-like layer and synchronized the contractions of their muscle cells to enable movement. The xenobots were able to move coherently for days or weeks, powered by embryonic energy stores. This level of functionality was a testament to the power of biological systems and the potential they hold for creating new forms of life.

In addition to their ability to move, the xenobots also demonstrated a surprising level of collective behavior. They were observed moving in circles and pushing pellets into a central location. This behavior was not programmed into them, but rather emerged spontaneously, further highlighting the complexity and adaptability of biological systems.

 

The Implications of Xenobots: A New Understanding of Life

The creation of the xenobots has significant implications for our understanding of how cells communicate and connect. It provides valuable insights into the complex processes that enable cells to work together to form functional organisms. This knowledge could be used to develop more effective treatments for diseases, create more efficient biofuels, and even help us understand the origins of life itself.

The potential applications of xenobots are vast and varied. They could be used for intelligent drug delivery, carrying medicines directly to the cells that need them. They could also be used for environmental clean-up tasks, such as gathering microplastics in the oceans or removing radioactive contamination. These applications are just the tip of the iceberg, and as our understanding of these organisms grows, so too will the range of potential uses.

However, the researchers also acknowledge the potential risks and unintended consequences of manipulating complex biological systems. They emphasize the need for society to better understand these systems and how to manipulate them to achieve desired behaviors. The creation of the xenobots is seen as a contribution towards this goal, providing a tangible example of what can be achieved through the manipulation of biological systems.

A manufactured quadruped organism, 650-750 microns in diameter.
Image credits Douglas Blackiston / Tufts University.

 

The Future of Biological Engineering

The research, titled “A scalable pipeline for designing reconfigurable organisms”, has been published in the journal Proceedings of the National Academy of Sciences. This publication marks a significant milestone in the field of biological engineering, and sets the stage for a future where the boundaries between life and machine become increasingly blurred.

 

Conclusion: The Brave New World of Xenobots

In conclusion, the creation of the xenobots represents a significant step forward in our understanding of life and our ability to manipulate it. It opens up a world of possibilities for the future, from intelligent drug delivery to environmental clean-up. However, it also serves as a reminder of the complexities and potential risks involved in manipulating biological systems. As we move forward into this brave new world, it is crucial that we proceed with caution, ensuring that our actions are guided by a deep understanding of the systems we are manipulating and the potential consequences of our actions.

At AHB Lab, we are at the forefront of biosynthetic technology, pioneering the development and supply of novel biosynthetic peptides and their commercialized products. Our proprietary Synthetic Biology Peptidomimetic Platform (SBPP) allows us to produce a wide range of peptides in a cost-effective and high-yield manner. We envision a future where biosynthetic technology, like the creation of xenobots, can be harnessed for a variety of applications, from healthcare to environmental conservation. As we continue to unlock the secrets of biosynthesis, we remain committed to pushing the boundaries of what is possible, creating tomorrow’s solutions today.

Leave a Reply

Your email address will not be published. Required fields are marked *

公司最新訊息

你的消炎藥只是在「關掉煙霧探測器」?從源頭阻斷慢性發炎的胜肽科學

為什麼你的疲倦與疼痛總是反覆發作? 你是不是經常覺得關節痠痛、莫名疲倦,或者有各種過敏和腸胃問題,卻始終找不出確切原因 ? 在現代高壓與快節奏的生活中,許多人都在尋求這些亞健康狀態的解藥。事實上,現代人90%的慢性病,其實都來自同一個源頭:你體內有一把撲不滅的「無名火」,醫學上稱之為「慢性發炎」 。 當面臨這些不適,多數人的第一反應是服用非類固醇消炎藥(NSAIDs)或類固醇。然而,這些傳統藥物往往只能提供短暫的舒緩,一旦停藥,症狀便會捲土重來。這不禁讓我們反思:我們是否只在處理表面症狀,而忽略了真正的問題根源?   傳統消炎藥的盲點與機制 要理解傳統藥物的局限性,我們必須先了解發炎的運作機制。當身體受到外界刺激時,免疫系統中的「巨噬細胞」會釋放 TNF-α 和 IL-1β 等發炎細胞因子 。這本是身體為了防禦而響起的警報器,但當免疫系統失衡,這些發炎因子便會失控形成「細胞因子風暴」,開始無差別攻擊正常細胞、黏膜和關節,甚至破壞 DNA 。 傳統的西藥如 NSAIDs 是如何運作的呢?它們主要的作用機制是抑制下游的 COX-1 或 COX-2 酵素 。 為了讓大家更直觀地理解,我們可以比較一下這兩種機制的差異:

Read More
公司最新訊息

止痛藥的隱形代價:淨火肽如何透過「8小時降解」機制重塑無毒抗炎新標準?

引言 在現代高壓的生活節奏中,面對關節痠痛或慢性疲勞,多數人的第一反應往往是去藥房購買非類固醇消炎止痛藥,或是服用醫生開立的類固醇 。當藥效發揮,疼痛的警報聲停止,我們便誤以為身體恢復了健康 。 然而,你吞下的那顆止痛藥,在讓你感覺不到痛之後,究竟去了哪裡? 這是一個多數消費者忽略,而品牌研發端必須正視的痛點。傳統藥物在體內的作用機制,實際上只是粗暴地抑制了下游的 COX 酵素 。這就像是一群莽漢直接砸爛了火災警報器,卻對真正引發火災的源頭無能為力 。更嚴重的是,這些無法被身體完全辨識與利用的化學合成物,在完成掩蓋任務後並不會憑空消失,而是轉化為化學廢棄物 。 這些殘留物迫使肝臟超負荷運作以進行代謝,同時也讓腎臟拼命處理排毒 。由於 COX 酵素被過度抑制,人體保護胃壁的機制隨之停擺,最終導致腸胃黏膜逐漸受到破壞 。這不是真正的治療,而是一場用內臟健康換取短暫不痛的恐怖交易 。身為保健或保養品牌的決策者,我們必須思考:除了這種「拆東牆補西牆」的化學療法,我們能否為市場提供一種更安全、無毒的解答?   核心機制深潛 為了解決傳統消炎藥物的瓶頸,富比積生物科技(AHB Lab)突破傳統藥理學限制,研發出名為「淨火肽 Healtide®」的第三代生物合成定序胜肽 。這項技術透過「生物黑客」的思維,重新定義了抗炎機制的標準。   1.

Read More
公司最新訊息

你體內的「無名火」正在搞破壞!一招從源頭撲滅慢性發炎(淨火肽 Healtide® 機理大解密)

為什麼吃了消炎藥,身體的「火」還是滅不掉? 你是否經常遇到這樣的客戶反饋:消費者面對關節痠痛、過敏、腸胃不適或皮膚慢性暗沉,長期服用非類固醇消炎藥(NSAIDs)或塗抹類固醇,卻總是反覆發作、治標不治本 ?   現代醫學與功能生物學證實:90% 的慢性疾病與老化瓶頸,核心源頭都來自體內撲不滅的「慢性發炎」。 傳統生技產品或化學藥物的開發邏輯,大多著眼於抑制下游的 COX-1 或 COX-2 酵素 。用一個心智模型(Mental Model)來比喻:這就像火災發生時,你只是跑去「關掉煙霧探測器」,卻根本沒有沒收那個正在不斷點火的「打火機」! 長期下來,不僅無法根除發炎,化學藥物更可能增加肝腎與腸胃道的代謝負擔 。 市場正在尋找一種更高訊噪比、能「從源頭斷火」且安全無副作用的革命性生物素材。這正是富比積生物科技(AHB Lab)董事長莊國昇博士與研發團隊,成功推出第三代生物合成定序胜肽——淨火肽(Healtide®)的契機 。   淨火肽(Healtide®)的源頭阻斷機制 當人體受到刺激時,免疫系統的「巨噬細胞」會釋放 TNF-α(腫瘤壞死因子)與 IL-1β 等發炎細胞因子 。一旦失控,就會引發無差別攻擊正常組織的「細胞因子風暴」

Read More